The Relative Strength (RS) Rating for MGIC Investment entered a new percentile Wednesday, with a rise from 78 to 81.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's unique rating measures share price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the best stocks tend to have an RS Rating north of 80 in the early stages of their moves.
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to establish and enter a buying range in heavy trade.
Earnings growth increased last quarter from 7% to 15%. But revenue gains fell from 6% to 4%.
The company holds the No. 9 rank among its peers in the Insurance-Property/Casualty/Title industry group. Root Cl A, Skyward Specialty Ins and Goosehead Insurance Cl A are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
